CureDM (part of Boston Therapeutics) Company
.png)
CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.
Industry:
Geroscience
Headquarters:
Wilmington, Delaware, United States
Zip:
1-10
Founded Date:
2004-01-01
Employees Number:
1-10
Acquisitions Number:
2
Investors Number:
4600000
Total Funding:
4600000
Estimated Revenue:
2018-02-13
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
contact@curedm.com
Register and Claim Ownership